"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
| Descriptor ID |
D000927
|
| MeSH Number(s) |
D27.505.954.427.080
|
| Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 1 | 4 |
| 2000 | 2 | 1 | 3 |
| 2001 | 3 | 0 | 3 |
| 2002 | 3 | 2 | 5 |
| 2003 | 4 | 0 | 4 |
| 2004 | 8 | 2 | 10 |
| 2005 | 5 | 3 | 8 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 2 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 4 | 0 | 4 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
Desirability of Outcome Ranking for Status Epilepticus: A Benefit-Risk Approach to Design and Analyses of Clinical SE Trials. Neurology. 2023 10 17; 101(16):e1633-e1639.
-
Gender Issues in Epileptic Patients. Neurol Clin. 2023 05; 41(2):249-263.
-
Why ketamine. Epilepsy Behav. 2023 04; 141:109066.
-
Valproic Acid Serum Concentration and Incidence of Toxicity in Pediatric Patients. J Child Neurol. 2022 05; 37(6):461-470.
-
Pregabalin for Recurrent Seizures in Critical Illness: A Promising Adjunctive Therapy, Especially for cyclic Seizures. Neurocrit Care. 2022 08; 37(1):140-148.
-
Effects of Epidiolex® (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study. Epilepsy Behav. 2022 Feb; 127:108538.
-
Levetiracetam compared with phenytoin or fosphenytoin in benzodiazepine-refractory pediatric status epilepticus. Acad Emerg Med. 2022 Jan; 29(1):125-127.
-
Early Neurologic Recovery, Practice Pattern Variation, and the Risk of Endotracheal Intubation Following Established Status Epilepticus. Neurology. 2021 05 11; 96(19):e2372-e2386.
-
Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia. Epilepsia. 2020 12; 61(12):2705-2711.
-
Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis. Epilepsy Behav. 2020 10; 111:107286.